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Abstract
Background: Carbapenemase producing Enterobacteriaceae are becoming a major public health concern globally,
however, relatively little is known about the molecular and clinical epidemiology of these organisms in many parts
of the world.
Methods: As part of a laboratory surveillance programme, 96 carbapenem non-susceptible Enterobacteriaceae
isolates from clinical samples from patients in seven hospitals were referred for investigation for carbapenemases.
Using polymerase chain reaction (PCR) to screen for a collection of genes encoding carbapenemases, 33 of 96
(34.5%) isolates were confirmed as carbapenemase producers. NDM-1 producers were the most prevalent at 64%
(21/33) whilst OXA-181 was the second most common carbapenemase constituting 24.5% (8/33) of the
carbapenemase producing isolates. Seven of these eight OXA-181 positive isolates underwent further
characterisation with screening for other transmissible antimicrobial resistance determinants using PCR. Clonal
relatedness was explored using Multilocus sequence typing (MLST) and Pulsed Field Gel Electrophoresis (PFGE).
Plasmid characterisation was performed including restriction analysis and transfer by conjugation or transformation.
Results: In addition to the OXA-181 gene, all contained other transmissible resistance determinants including
extended spectrum β-lactamases, oxacillinases or 16S rRNA methylase genes, but none contained
metallo-β-lactamases or serine carbapenemases. All isolates had a multidrug resistant phenotype with two isolates
being resistant to every antibiotic tested including colistin. Multilocus sequence typing confirmed five isolates
belonged to ST17 and two to ST14, with those belonging to the same sequence type having identical PFGE
profiles. The OXA-181 gene was typically carried on large plasmids which were mostly non-conjugative.
Conclusions: OXA-181 carbapenemase appears to be an important and probably under-recognised cause of
carbapenem resistance in Enterobacteriaceae in Singapore. Further coordinated research into clinical and molecular
epidemiology of carbapenemases is urgently required in Singapore and throughout Asia.
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Background
Acquired resistance to carbapenems in Enterobacteriaceae
is a major concern worldwide. This is due both to their
importance as human pathogens especially within the
hospital setting, and to the highly transmissible nature and
propensity for rapid spread shown by these organisms. An
increasingly diverse range of enzymes are being recog-
nised as significant, including serine proteases of Ambler
Class A, the Class B metallo-β-lactamases and carbapenem-
hydrolysing Class D oxacillinases [1]. Originally found in
Shewanella species, OXA-48-like carbapenemases have now
emerged in Enterobacteriaceae, predominantly Klebsiella
pneumoniae. These carbapenem hydrolysing Class D β-
lactamases are unusual among carbapenemases in their
weak hydrolysis of cephalosporins and resistance to inhibi-
tors such as clavulanate, making them difficult to identify
in the laboratory [2]. OXA-181, a variant of OXA-48, was
initially reported in India but has been sporadically detected
in the United Kingdom, The Netherlands, France, New
Zealand, Oman and Singapore [2-7]. Molecular character-
isation of this emerging variant remains limited.
Until recently, the vast majority of carbapenem resistance
in this group of organisms was due to extended spectrum
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β-lactamase (ESBL) or AmpC cephalosporinase production
combined with impermeability due to porin mutations [8].
Carbapenemase producing organisms were infrequently
reported. Between October 2010 and March 2012, we
screened 96 Enterobacteriaceae clinical isolates with MIC ≥
2 mg/L to meropenem or imipenem for acquired carbape-
nemases using polymerase chain reaction (PCR). Isolates
were referred for investigation from seven of eight (87.5%)
hospital or community laboratories in Singapore after
initial antimicrobial susceptibility testing showed non-
susceptibility to carbapenems. Epidemiological data was
not provided by referring laboratories. Carbapenemase
genes were detected in 33 (33/96, 34.4%), including eight
clinical isolates of OXA-181-producing Klebsiella pneumo-
niae from patients in three different hospitals. NDM-1 pro-
ducing isolates dominated this study at 64% (21/33) whilst
OXA-181 producers constituted 24.5% (8/33) of carbapene-
mase producing isolates thus making blaOXA-181 the second
most detected carbapenemase gene after blaNDM-1 [9]. The
remaining were KPC producers (4/33) [10]. Here, we report
the molecular characterisation of seven out of the eight of
the OXA-181 producing isolates. One isolate was excluded
from analysis as consent was not obtained from the refer-
ring laboratory.
Methods
All isolates were confirmed as K. pneumoniae using matrix
assisted laser desorption ionisation-time of flight-mass
spectrometry (MALDI-ToF-MS, Bruker Daltonics GmHB,
Bremen, Germany). Antimicrobial susceptibility testing was
performed with VITEK-2 instrument and carbapenem MICs
confirmed with Etest (bioMérieux, Marcy L’Etoile, France)
with susceptibility defined according to European Com-
mittee on Antimicrobial Susceptibility Testing (EUCAST)
breakpoints. Presence of carbapenemases were screened
phenotypically using disc diffusion assays with merope-
nem discs supplemented with boronic acid, cloxacillin or
dipicolinic acid (Rosco Diagnostica A/S, Taastrup, Denmark)
and the modified Hodge test [11].
Isolates underwent screening for transmissible β-lactamase
genes including serine carbapenemases (KPC-type), metallo-
β-lactamases (MBL; NDM-type, VIM-type, IMP-type), oxa-
cillinases and extended spectrum β-lactamases (ESBL; TEM-
type, SHV-type, CTX-M-type) with PCR followed by se-
quencing of amplicons [9,10]. Detection of blaOXA was
based on a multiplex PCR assay developed by Woodford
et al. [12] with addition of blaOXA-48-like primers (OXA-
48L 50- GTGGGATGGACAGACGCG-30 and OXA-48 LL
50-CCACACATTATCATCAAGTTC-30) using National Col-
lection of Type Cultures (NTCT) 13442 K. pneumoniae as
positive control for blaOXA-48. Plasmid mediated 16S rRNA
methylase aminoglycoside resistance determinants (armA,
rmtA, rmtB, rmtC, rmtD and npmA) were also analysed
by PCR.
Clonal relatedness was investigated using Multilocus se-
quence typing (MLST, www.pasteur.fr/recherche/genopole/
PF8/mlst) and Pulsed Field Gel Electrophoresis (PFGE)
of SpeI (New England Biolabs, Ipswich, MA) digested
genomic DNA [13].
The number and size of plasmids were analysed by S1
nuclease digestion of whole genomic DNA followed by
PFGE (S1-PFGE) [14]. In addition, smaller plasmids were
extracted using the QIAprep spin miniprep kit (Qiagen
GmbH, Hilden, Germany). Southern hybridisation using
a digoxigenin (DIG) labelled blaOXA-181 probe (DIG DNA
Labelling and Detection kit, Roche Diagnostics, Mannheim,
Germany) was used to localise blaOXA-181. Transformation
studies were performed with plasmid DNA extracted using
QIAprep Spin Miniprep kit introduced by electropor-
ation into E. coli DH5α cells using Gene Pulser Xcell
(Bio-Rad, Hercules, CA) with transformants selected on
Luria-Bertani (LB) agar supplemented with imipenem
(1 mg/L). Conjugation experiments were performed be-
tween K. pneumoniae isolates and azide-resistant recipient
E.coli J53 with transconjugants selected on LB agar con-
taining sodium azide (50 mg/L) and imipenem (1 mg/L).
PCR-based replicon typing was used to identify plasmid in-
compatibility groups [15]. To analyse the immediate genetic
environment of the blaOXA-181 gene in our isolates, primers
(IRF 50-CCTAGATTCTACGTCAGTAC-30 and IRR2 50-
CTCTCTAGTCGGACAACACC-30) based on GenBank
reference sequence NC_019160.1, designed to walk in
from the left and right inverted long repeats (IRL) in the
direction of blaOXA-181 were used.
Results and discussion
As part of a surveillance program for carbapenem non-
susceptible Enterobacteriaceae in Singapore, 96 isolates
from seven hospitals or private laboratories were submit-
ted for investigation. Of these, 33 clinical isolates con-
tained carbapenemase genes as detected by PCR with
eight isolates bearing blaOXA-181. Consent from referring
laboratories was obtained for seven of these isolates to
be subjected to molecular characterisation. The blaOXA-181
positive clinical isolates were confirmed as Klebsiella
pneumoniae by MALDI-ToF MS. Most showed high level
resistance to carbapenems, and interestingly also to cepha-
losporins (Table 1), suggesting the presence of other resist-
ance determinants in addition to blaOXA-181. Two of the
seven isolates were resistant to all antimicrobial agents
tested including colistin. All seven OXA-181 producers
were positive by the modified Hodge test. No synergy was
detected using disc diffusion assays, the usual pattern seen
with oxacillinase presence.
Full gene sequencing of amplicons revealed 100% iden-
tity with blaOXA-181 [GenBank: JN205800.1]. PCR screen-
ing and sequencing showed that all isolates also carried
ESBL genes and at least one additional blaOXA-type but
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Table 1 Characteristics of OXA-181-producing Klebsiella pneumoniae clinical isolates
Isolate Hospital Specimen Date of Isolation ST 16S rRNA
methylase
gene





IMP MEM ETP FOX CTX CAZ AZT COL TGC LEV GEN AMK
KPO8 Hospital A Tracheal
aspirate




A/C >32 >32 >32 >256 >256 64 >256 0.125 2 0.25 >256 >256




A/C >32 >32 >32 >256 >256 64 >256 16 >256 >256 >256 >256
KPO7 Hospital A Tracheal
aspirate






A/C, F >32 >32 >32 >256 >256 >256 >256 0.25 12 >256 >256 >256





A/C >32 >32 >32 >256 >256 >256 >256 32 4 >256 >256 96






A/C 8 8 >32 >256 >256 >256 >256 0.25 16 >256 >256 >256






A/C, F 4 4 >32 >256 >256 >256 >256 0.25 8 >256 >256 >256
KPO83 Hospital C Urine 30/12/2011 14 armA TEM-1, SHV-1,
CTX-M-15, OXA-1,
OXA-9
~170 A/C 32 8 >32 >256 >256 >256 >256 0.5 16 32 >256 >256
KPO9–T ― ― ― ― armA OXA-181, CTX-M-
15
~170 A/C 2 0.5 0.5 2 3 1 0.75 0.125 0.125 0.002 >256 >256
KPO26 –
T
― ― ― ― ND OXA-181, OXA-9 ~194 A/C 2 0.19 0.25 12 6 2 6 0.125 0.125 0.003 0.125 1
E. coli
J53
― ― ― ― ― ― ― ― 0.125 0.016 0.04 1 0.064 0.25 0.064 0.125 0.064 0.004 0.125 0.125
Legend:
MIC, minimum inhibitory concentration; IPM, imipenem; MEM, meropenem; ETP, ertapenem; FOX, cefoxitin; CTX, cefotaxime; CAZ, ceftazidime; AZT, aztreonam; COL, colistin; TCG, tigecycline; LEV, levofloxacin; GEN,




















none were positive for MLBs or KPC-type β-lactamases
(Table 1). armA was detected in six of the seven isolates
(Table 1). MLST revealed five isolates of sequence type
(ST)14 and two of ST17. Furthermore, isolates belonging
to the same sequence type had identical PFGE patterns.
OXA-181-producing isolates came from three different
hospitals over a 15 month period, and to our knowledge
patients did not have an epidemiological link to each other
although full data is not accessible.
Analysis of plasmid content using miniprep kit extrac-
tions and S1-PFGE revealed the isolates contained mul-
tiple small (~1.5kb) and large plasmids (~50 - ~194kb)
(Table 1). Southern hybridization studies using a blaOXA-181
probe localised the gene to a large plasmid of ~170kb in six
of the seven clinical isolates and to a ~194kb plasmid in
isolate KPO26 (Table 1). Transformation studies were not
successful in selecting transformants; however, the method
would have only extracted small plasmids. This would sup-
port localisation of blaOXA-181 to large plasmids. Previously
blaOXA-181 has been described in a range of plasmid back-
bones ranging from a small ColE2-type plasmid of ~7.6kb
in K. pneumoniae KP3 to large plasmids of 200-250kb
[3,16]. Transconjugants were obtained for only two iso-
lates (KPO-9, KPO-26) with transfer of a large plasmid
carrying blaOXA-181 demonstrated by S1-PFGE and Southern
hybridization analysis (data not shown). Transconjugant
KPO-26 remained susceptible to non-β-lactam antibio-
tics whilst for KPO-9, armA was co-transferred with the
plasmid (Table 1).
To further characterize the plasmids, PCR- based replicon
typing was performed. IncA/C replicons were detected in
all isolates including the transconjugants (Table 1), suggest-
ing blaOXA-181 was present on an IncA/C plasmid although
Southern hybridisation analysis using IncA/C probes would
be needed to confirm this. Plasmids belonging to the
IncA/C incompatibility group are of interest as they carry
resistance to diverse groups of antimicrobial agents and
have a broad host range [17].
blaOXA-181 has been found as part of transposon, Tn2013,
with upstream insertion sequence ISEcp1 mediating one-
ended transposition of the blaOXA-181 gene [16]. The im-
mediate genetic environment surrounding blaOXA-181 of
our isolates was investigated. Gene mapping demonstrated
presence of the ISEcp1 element upstream, however, no
PCR products were obtained when attempting to amplify
downstream sequences (Δlys and Δere). This raises the
possibility that blaOXA-181 in our isolates could be present
in a structure different to the previously characterized
Tn2013 [16].
The surveillance project from which these isolates were
derived is ongoing. This project has previously identified
that NDM-1 containing organisms appear to be well
established in different Enterobacteriaceae species, often
in patients without travel history within the preceding
year and that KPC-2-producing Klebsiella pneumoniae
has been introduced to Singapore probably from main-
land China [9,10]. Our work suggests that blaOXA-181
may already have established on plasmids within success-
ful K. pneumoniae strains in Singapore. There is also the
likelihood that a much wider reservoir of carbapenemase-
producing Enterobacteriaceae already exists here given
that this is a voluntary programme and only clinical iso-
lates with obviously elevated carbapenem MICs were
referred for investigation. This could be especially true
for organisms carrying OXA-48-like carbapenemases which
may not exhibit high level resistance to carbapenems or
cephalosporins in the absence of other resistance determi-
nants capable of conferring carbapenem non-susceptibility.
A major limitation of our study is that clinical data on
patients from whom the isolates were obtained is lacking.
Although all isolates studied in this collection came from
clinical samples, no data is available on whether these rep-
resent colonisation or true infection, nor regarding treat-
ment and outcomes. This makes establishing the context of
carbapenem resistance in Enterobacteriaceae in Singapore
more difficult. Indeed, any data on carbapenemase-
producing Enterobacteriaceae is very limited in South East
Asia. Given the frequency of travel and economic migration
through many parts of the region and the widespread re-
sistance to other antimicrobial classes, carbapenemase
production in Enterobacteriaceae is likely to be an under-
estimated entity, made more difficult by the lack of avail-
ability for diagnostic testing in many areas.
Conclusion
OXA-181 carbapenemase appears to be an emerging and
probably under-recognised cause of carbapenem resistance
in Enterobacteriaceae in Singapore. This preliminary data,
along with the work of others [7], has provided the basis
for establishing further coordinated clinical and molecular
epidemiological research into carbapenemase-producing
Enterobacteriaceae in Singapore aimed at addressing many
of the gaps in our current understanding.
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